Olaratumab (Lartruvo) - Oncology Nurse Advisor
Skip to navigation Skip to main content

Olaratumab (Lartruvo)

Slideshow

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

This slideshow reviews olaratumab (Lartruvo), indicated for the treatment of soft tissue sarcoma with a histologic subtype for which an anthracycline-containing regimen is appropriate and which is not amenable to curative treatment with radiotherapy or surgery.

Table of Contents

Slide 4: Dosage and Administration
Slide 10: Cautions, Effects, and Interactions
Slide 16: What to Tell Your Patient
Slide 21: Reference

Topics:

Drug Information Slideshows Stat Consult
Next hm-slideshow in Slides